Identification of varicella-zoster virus-specific CD8 T cells in patients after T-cell-depleted allogeneic stem cell transplantation

Journal of Virology

Volumn 83, Issue 14, 2009, Pages 7361-7364

  Van Der Heiden, Pim L J ^a   De Boer, Renate ^a   Van Der Steen, Dirk M ^a   Kester, Michel G D ^a   Van Der Hoorn, Menno W A G ^a   Haarman, Wilmy M E ^a   Barnby Porritt, Helen E ^b   Fry, Jeremy W ^b   Napper, C E ^b   Marijt, Erik W A ^a   Willemze, Roel ^a   Falkenburg, J H Frederik ^a   Heemskerk, Mirjam H M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ProImmune Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A2 ANTIGEN; IMMEDIATE EARLY PROTEIN; VIRUS PROTEIN;

ALLOGENEIC STEM CELL TRANSPLANTATION; ANIMAL CELL; ARTICLE; CD8+ T LYMPHOCYTE; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; VARICELLA ZOSTER VIRUS; VIRUS REACTIVATION;

CD8-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HLA-A2 ANTIGEN; HUMANS; IMMEDIATE-EARLY PROTEINS; POSTOPERATIVE COMPLICATIONS; STEM CELL TRANSPLANTATION; TRANS-ACTIVATORS; TRANSPLANTATION, HOMOLOGOUS; VIRAL ENVELOPE PROTEINS;

HUMAN HERPESVIRUS 3;

EID: 67650395615     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02662-08     Document Type: Article

References (14)

1. Arvin, A. M., E. Kinney-Thomas, K. Shriver, C. Grose, C. M. Koropchak, E. Scranton, A. E. Wittek, and P. S. Diaz. 1986. Immunity to varicella-zoster viral glycoproteins, gp I (gp 90/58) and gp III (gp 118), and to a nonglycosylated protein, p 170. J. Immunol. 137:1346-1351.
2. + phenotype. J. Immunol. 146:257-264.
3. Burrows, S. R., N. Kienzle, A. Winterhalter, M. Bharadwaj, J. D. Altman, and A. Brooks. 2000. Peptide-MHC class I tetrameric complexes display exquisite ligand specificity. J. Immunol. 165:6229-6234.
4. + T-cell response to IE62, by use of IE62 peptides after varicella vaccination. J. Infect. Dis. 188:40-52.
5. Heemskerk, M. H., M. Hoogeboom, R. A. de Paus, M. G. Kester, M. A. van der Hoorn, E. Goulmy, R. Willemze, and J. H. Falkenburg. 2003. Redirection of antileukemic reactivity of peripheral T lymphocytes using gene transfer of minor histocompatibility antigen HA-2-specific T-cell receptor complexes expressing a conserved alpha joining region. Blood 102:3530-3540.
6. + T cells after primary infection. J. Virol. 80:9772-9778.
7. Kalpoe, J. S., A. C. Kroes, S. Verkerk, E. C. Claas, R. M. Barge, and M. F. Beersma. 2006. Clinical relevance of quantitative varicella-zoster virus (VZV) DNA detection in plasma after stem cell transplantation. Bone Marrow Transplant. 38:41-46.
8. Kinchington, P. R., K. Fite, and S. E. Turse. 2000. Nuclear accumulation of IE62, the varicella-zoster virus (VZV) major transcriptional regulatory protein, is inhibited by phosphorylation mediated by the VZV open reading frame 66 protein kinase. J. Virol. 74:2265-2277.
9. Kinchington, P. R., J. K. Hougland, A. M. Arvin, W. T. Ruyechan, and J. Hay. 1992. The varicella-zoster virus immediate-early protein IE62 is a major component of virus particles. J. Virol. 66:359-366.
10. Koc, Y., K. B. Miller, D. P. Schenkein, J. Griffith, M. Akhtar, J. DesJardin, and D. R. Snydman. 2000. Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome. Biol. Blood Marrow Transplant. 6:44-49.
11. Parker, K. C., M. A. Bednarek, and J. E. Coligan. 1994. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J. Immunol. 152:163-175.
12. Rammensee, H., J. Bachmann, N. P. Emmerich, O. A. Bachor, and S. Stevanovic. 1999. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50:213-219.
13. Sadzot-Delvaux, C., P. R. Kinchington, S. Debrus, B. Rentier, and A. M. Arvin. 1997. Recognition of the latency-associated immediate early protein IE63 of varicella-zoster virus by human memory T lymphocytes. J. Immunol. 159:2802-2806.
14. + T cells on reexposure to varicella-zoster virus. J. Infect. Dis. 190:72-82.